Maynard Um
-
-
-
-
-
-
-
Arvinas Inc. (ARVN) PT Raised to $15 at Stephens
-
-
-
-
-
-
-
Arvinas Inc. (ARVN) PT Raised to $16 at Piper Sandler
-
-
-
-
-
-
-
Arvinas Inc. (ARVN) PT Lowered to $14 at Stephens
-
-
-
-
-
-
-
Arvinas (ARVN) stock rises on FDA submission with Pfizer (PFE)
-
-
-
-
-
-
-
Arvinas Inc. (ARVN) PT Lowered to $9.50 at Citi
-
-
-
-
-
-
-
Arvinas (ARVN) Announces Results from the VERITAC-2 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Arvinas Inc. (ARVN)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

